Pembrolizumab (pembro) for locally advanced (LA) or recurrent/metastatic (R/M) cutaneous squamous cell carcinoma (cSCC): Long-term results of the phase 2 KEYNOTE-629 study

被引：0
|
作者：
Couselo, Eva Munoz
Hughes, Brett Gordon Maxwell
Mortier, Laurent
Grob, Jean-Jacques
Gutzmer, Ralf
Roshdy, Osama
Mendoza, Rene Lazaro Gonzalez
Schachter, Jacob
Arance, Ana Maria
Grange, Florent
Meyer, Nicolas
Joshi, Abhishek Jagdish
Billan, Salem
Ojavee, Sven Erik
Yuan, Jianda
Gumuscu, Burak
Bratland, Ase
机构：
[1] Hosp Valle De Hebron, Barcelona, Spain
[2] Vall dHebron Inst Oncol VHIO, Barcelona, Spain
[3] Royal Brisbane & Womens Hosp, Herston, Qld, Australia
[4] Univ Queensland, Brisbane, Qld, Australia
[5] CHRU Lille, Hop Claude Huriez, Lille, France
[6] Aix Marseille Univ, Hop Timone, Marseille, France
[7] Ruhr Univ Bochum, Johannes Wesling Med Ctr, Minden, Germany
[8] Jewish Gen Hosp, Montreal, PQ, Canada
[9] Ctr Estatal Cancerol Chihuahua, Chichuahua, Mexico
[10] Chaim Sheba Med Ctr Tel HaShomer, Ramat Gan, Israel
[11] Hosp Clin Barcelona, Barcelona, Spain
[12] IDIBAPS, Barcelona, Spain
[13] Ctr Hosp Univ Reims, Hop Robert Debre, Reims, France
[14] Inst Univ Canc, Toulouse, France
[15] CHU Toulouse, Toulouse, France
[16] Townsville Univ Hosp, Townsville, Qld, Australia
[17] Rambam Hlth Care Campus, Haifa, Israel
[18] Merck & Co Inc, Rahway, NJ 07065 USA
[19] Oslo Univ Sykehus, Oslo, Norway
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9554
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase 2 study of pembrolizumab (pembro) for locally advanced (LA) or recurrent/metastatic (R/M) cutaneous squamous cell carcinoma (cSCC): KEYNOTE-629.
    Hughes, Brett G. M.
    Munoz-Couselo, Eva
    Mortier, Laurent
    Bratland, Ase
    Gutzmer, Ralf
    Roshdy, Osama
    Gonzalez Mendoza, Rene
    Schachter, Jacob
    Arance, Ana
    Grange, Florent
    Meyer, Nicolas
    Joshi, Abhishek
    Billan, Salem
    Zhang, Pingye
    Gumuscu, Burak
    Swaby, Ramona F.
    Grob, Jean-Jacques
    CANCER RESEARCH, 2021, 81 (13)
  • [2] KEYNOTE-629: Phase 2 study of pembrolizumab for recurrent/metastatic or locally advanced unresectable cutaneous squamous cell carcinoma (cSCC).
    Grob, Jean Jacques
    Gonzalez, Rene
    Basset-Seguin, Nicole
    Schachter, Jacob
    Vornicova, Olga
    Bauman, Jessica Ruth
    Grange, Florent
    Meyer, Nicolas
    Piulats, Josep M.
    Zhang, Eric
    Gumuscu, Burak
    Swaby, Ramona F.
    Hughes, Brett Gordon Maxwell
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] KEYNOTE-629: Efficacy of pembrolizumab (Pembro) per immune-related RECIST (irRECIST) in locally advanced (LA) and recurrent or metastatic (R/M) cutaneous squamous cell carcinoma (cSCC)
    Munoz Couselo, E.
    Hughes, B. G. M.
    Bratland, A.
    Gutzmer, R.
    Roshdy, O.
    Gonzalez Mendoza, R.
    Schachter, J.
    Arance Fernandez, A. M.
    Grange, F.
    Meyer, N.
    Joshi, A. J.
    Billan, S.
    Grob, J. J.
    Zhang, P.
    Gumuscu, B.
    Swaby, R.
    Mortier, L.
    ANNALS OF ONCOLOGY, 2021, 32 : S1444 - S1445
  • [4] Pembrolizumab in patients with recurrent or metastatic cutaneous squamous cell carcinoma (cSCC): The phase II KEYNOTE-629 study
    Licitra, L. F.
    Siu, L. L.
    Cohen, E. E. W.
    Zhang, P.
    Gumuscu, B.
    Swaby, R.
    Harrington, K.
    ANNALS OF ONCOLOGY, 2018, 29
  • [5] KEYNOTE-629: Health-related quality of life (HRQoL) with pembrolizumab (pembro) in patients (pts) with locally advanced (LA) or recurrent or metastatic (R/M) cutaneous squamous cell carcinoma (cSCC).
    Bratland, Ase
    Munoz-Couselo, Eva
    Mortier, Laurent
    Roshdy, Osama
    Gonzalez, Rene
    Schachter, Jacob
    Arance, Ana Maria
    Grange, Florent
    Meyer, Nicolas
    Joshi, Abhishek Jagdish
    Billan, Salem
    Hughes, Brett Gordon Maxwell
    Grob, Jean-Jacques
    Ramakrishnan, Karthik
    Zhang, Eric
    Gumuscu, Burak
    Swaby, Ramona F.
    Gutzmer, Ralf
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [6] KEYNOTE-629: Phase 2 trial of pembrolizumab in patients (pts) with recurrent or metastatic cutaneous squamous cell carcinoma (cSCC)
    Licitra, L.
    Siu, L.
    Cohen, E.
    Zhang, P.
    Gumuscu, B.
    Swaby, R.
    Harrington, K.
    ANNALS OF ONCOLOGY, 2017, 28
  • [7] KEYNOTE-629: Phase II study of pembrolizumab for recurrent/metastatic or locally advanced unresectable cutaneous squamous cell carcinoma
    Grob, Jean-Jacques
    Gonzalez Mendoza, Rene
    Basset-Seguin, Nicole
    Schachter, Jacob
    Vornicova, Olga
    Bauman, Jessica
    Grange, Florent
    Meyer, Nicolas
    Piulats, Josep
    Zhang, Pingye
    Gumuscu, Burak
    Swaby, Ramona
    Hughes, Brett G. M.
    CANCER RESEARCH, 2019, 79 (13)
  • [8] Pembrolizumab for recurrent/metastatic cutaneous squamous cell carcinoma (cSCC): Efficacy and safety results from the phase II KEYNOTE-629 study
    Grob, J. J.
    Gonzalez Mendoza, R.
    Basset-Seguin, N.
    Vornicova, O.
    Schachter, J.
    Joshi, A.
    Meyer, N.
    Grange, F.
    Piulats, J. M.
    Bauman, J.
    Zhang, P.
    Gumuscu, B.
    Swaby, R. F.
    Hughes, B. G. M.
    ANNALS OF ONCOLOGY, 2019, 30 : 908 - 908
  • [9] Health-Related Quality of Life with Pembrolizumab in Patients with Locally Advanced or Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: KEYNOTE-629
    Åse Bratland
    Eva Munoz-Couselo
    Laurent Mortier
    Osama Roshdy
    Rene González
    Jacob Schachter
    Ana M. Arance
    Florent Grange
    Nicolas Meyer
    Abhishek Jagdish Joshi
    Salem Billan
    Brett G. M. Hughes
    Jean-Jacques Grob
    Karthik Ramakrishnan
    Joy Ge
    Burak Gumuscu
    Ramona F. Swaby
    Ralf Gutzmer
    Dermatology and Therapy, 2023, 13 : 3165 - 3180
  • [10] Health-Related Quality of Life with Pembrolizumab in Patients with Locally Advanced or Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: KEYNOTE-629
    Bratland, Ase
    Munoz-Couselo, Eva
    Mortier, Laurent
    Roshdy, Osama
    Gonzalez, Rene
    Schachter, Jacob
    Arance, Ana M.
    Grange, Florent
    Meyer, Nicolas
    Joshi, Abhishek Jagdish
    Billan, Salem
    Hughes, Brett G. M.
    Grob, Jean-Jacques
    Ramakrishnan, Karthik
    Ge, Joy
    Gumuscu, Burak
    Swaby, Ramona F.
    Gutzmer, Ralf
    DERMATOLOGY AND THERAPY, 2023, 13 (12) : 3165 - 3180
12345